Postoperative Telerehabilitation in Older Adults

NCT05435885 | Completed Results DMC

• 1 other identifier: 2205-033-114
• Study Type: interventional
• Target: 64
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to confirm the effectiveness of a mobile messenger-based home tele-rehabilitation protocol in patients who have undergone lung resection surgery. By analyzing the difference from the existing postoperative pulmonary rehabilitation, the investigators would like to propose a new pulmonary tele-rehabilitation protocol.

Conditions

Telerehabilitation; Carcinoma, Non-Small-Cell Lung; Cardiopulmonary Exercise Test

Outcome Measures

Primary Outcomes (1)

• Change From Baseline in VO2 Peak (Peak Oxygen Uptake, mL/kg/Min) on the CardioPulmonary Exercise Test(CPET) After 4 Weeks Intervention

  Cardiopulmonary exercise test (CPET) also referred to as a VO2 (oxygen consumption) test, is a specialized type of stress test or exercise test that measures participants exercise ability.

  Before surgery (Pre), Baseline (4 weeks after surgery), After intervention(8 weeks after surgery), Follow up(12 weeks after surgery)

Secondary Outcomes (11)

• Ventilatory Efficiency (VE/VCO₂ Slope)

  Immediately After Rehabilitation and at 4-Week Follow-Up

• Maximal Inspiratory Pressure (MIP)

  Immediately After Rehabilitation and at 4-Week Follow-Up

• Skeletal Muscle Index (SMI)

  Immediately After Rehabilitation and at 4-Week Follow-Up

• Hospital Anxiety and Depression Scale (HADS)

  Immediately After Rehabilitation and at 4-Week Follow-Up

• EQ-5D (EuroQol-5 Dimension)

  Immediately After Rehabilitation and at 4-Week Follow-Up

Study Arms (2)

Tele-rehabilitation group

EXPERIMENTAL

The Tele-rehabilitation group performs 12 training sessions during four weeks. (3 sessions/week)

Other: Pulmonary Tele-Rehabilitation

Control group

OTHER

The control group receives usual care with only one educational session.

Other: Control (Education)

Interventions

Pulmonary Tele-Rehabilitation OTHER

12 supervised training sessions via a specific mobile messenger during four weeks. (3 sessions/week)

Tele-rehabilitation group

Control (Education) OTHER

Usual care with only one educational session.

Control group

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• A person who is suspected of lung cancer and is scheduled to undergo a thoracoscopic lung resection surgery.
• men and women the age ≥65 years.
• A person who understands the course of the clinical trial and signs the informed consent form.

You may not qualify if:

• Patients whose activity is restricted due to other diseases (e.g. osteoarthritis, spinal disease, cerebral infarction, etc.)
• Patients who cannot test bioimpedance analysis due to the insertion of artificial pacemakers and defibrillators
• A person who has difficulty judging himself/herself due to dementia, etc
• Those enrolled in other clinical trials
• A person deemed inappropriate to participate in this clinical trial under the judgement of the investigator.
• A person who cannot use mobile messenger

Sponsors & Collaborators

• Pusan National University Hospital: lead
• National Research Foundation of Korea: collaborator

Study Sites (1)

PusanNUH

Pusan, South Korea

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic Factors; Population Characteristics

Results Point of Contact

• Title: Dr. Sanghun Kim
• Organization: Department of Rehabilitation Medicine, Pusan National University Hospital

kel5504@gmail.com

82-51-240-7485

Study Officials

• Sang Hun Kim, M.D.,Ph.D.

  Pusan National University Hospital

  STUDY DIRECTOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 23, 2022
• First Posted: June 28, 2022
• Study Start: July 25, 2022
• Primary Completion: February 16, 2024
• Study Completion: February 16, 2024
• Last Updated: June 17, 2025
• Results First Posted: June 17, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

KR (1)